跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 20 条关于
“mutCALR”
全部
20
临床试验
12
药物
0
机构
1
资讯
7
9个月前
FDA Grants Breakthrough Therapy Designation to Incyte's First-in-Class mutCALR-Targeted Antibody for Essential Thrombocythemia
10个月前
Incyte Partners with Enable Injections to Develop Subcutaneous Delivery System for First-in-Class mutCALR Therapy
10个月前
Galecto Completes $285M Acquisition of Damora Therapeutics to Advance Rare Blood Cancer Pipeline
10个月前
Incyte Showcases First-in-Class Mutant Calreticulin Antibody INCA033989 at ASH 2025 with Over 50 Presentations
8个月前
Galecto Strengthens Leadership Team with Blueprint Medicines Veterans as DMR-001 Advances Toward Clinical Trials
去年
Incyte Reports Strong Q2 2025 Results with Jakafi Growth and New Drug Approvals
9个月前
Prelude Therapeutics Unveils Novel JAK2V617F-Selective Inhibitor and mCALR-Targeted Therapy for Myeloproliferative Neoplasms